Abstract:Advances in technology and reduced costs are facilitating large-scale sequencing of genes and exomes as well as entire genomes. Recently, we described an approach based on haplotypes called SCARVA 1 that enables the simultaneous analysis of the association between rare and common variants in disease etiology. Here, we describe an extension of SCARVA that evaluates individual markers instead of haplotypes. This modified method (SCARVAsnp) is implemented in four stages. First, all common variants in a pre-specified region (eg, gene) are evaluated individually. Second, a union procedure is used to combined all rare variants (RVs) in the index region, and the ratio of the log likelihood with one RV excluded to the log likelihood of a model with all the collapsed RVs is calculated. On the basis of previously-reported simulation studies, 1 a likelihood ratio ≥ 1.3 is considered statistically significant. Third, the direction of the association of the removed RV is determined by evaluating the change in λ values with the inclusion and exclusion of that RV. Lastly, significant common and rare variants, along with covariates, are included in a final regression model to evaluate the association between the trait and variants in that region. We apply simulated and real data sets to show that the method is simple to use, computationally effcient, and that it can accurately identify both common and rare risk variants. This method overcomes several limitations of existing methods. For example, SCARVAsnp limits loss of statistical power by not including variants that are not associated with the trait of interest in the final model. Also, SCARVAsnp takes into consideration the direction of association by effectively modelling positively and negatively associated variants.

Bayesian model comparison for rare-variant association studies

Identifying rare variants using a Bayesian regression approach

A Probabilistic Method for Identifying Rare Variants Underlying Complex Traits

A Robust Model-free Approach for Rare Variants Association Studies Incorporating Gene-Gene and Gene-Environmental Interactions

Rare coding variant analysis for human diseases across biobanks and ancestries

Rare variant effect estimation and polygenic risk prediction

A statistical framework for powerful multi-trait rare variant analysis in large-scale whole-genome sequencing studies

A Variational Bayes Discrete Mixture Test for Rare Variant Association

Extending Rare-Variant Testing Strategies: Analysis of Noncoding Sequence and Imputed Genotypes

A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions.

Meta-analysis of Gene-Level Tests for Rare Variant Association.

The functional impact of rare variation across the regulatory cascade

A Comparison of Latent Class Model and Principal Component Analysis in the Application of Rare Variants Association Studies

Methods for Association Analysis and Meta‐Analysis of Rare Variants in Families

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Bayesian network-based Mendelian randomization for variant prioritization and phenotypic causal inference

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics

Reciprocal causation mixture model for robust Mendelian randomization analysis using genome-scale summary data

Simultaneous Analysis of Common and Rare Variants in Complex Traits: Application to SNPs (Scarvasnp)

Association Analysis and Meta-Analysis of Multi-Allelic Variants for Large-Scale Sequence Data